UNSPSC 51384610: Edaravone or norphenazone
Commodity
Code facts
- Part of
-
-
51000000
-
51380000
- 51384600
-
51380000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51384610
Definition
This classification denotes a neuroprotective agent with the molecular structure C10H10N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, S798V6YJRP chemically known as 3h-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl- but generally known as edaravone, which bears US NIH Compound Identifier 4021. European Medicines Agency schedules Edaravone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06453MIG.
The term EDARAVONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 10, no. 3, 1996, list 36). Edaravone or norphenazone bears US NLM identifiers UMLS ID C0070694 and NCI Concept Code C74323. SMILES: O=C1N(N=C(C1)C)C1CCCCC1.
About UNSPSC 51384610
UNSPSC 51384610 Edaravone or norphenazone is a Commodity code that nominally describes pharmaceutical compounds, but the recent state and local contracting activity under this code does not align with that scope. The single recent opportunity posted—Seminole County, Florida's IFB60459723LAS in June 2026—solicits naloxone and safe drug deactivation systems, which fall outside the code's stated pharmaceutical focus and suggest a mismatch between the code assignment and the actual procurement. State and local governments posting under this code appear limited to health and safety agencies; the Seminole County opportunity names the Community Health Building as the delivery site and frames the purchase as supporting community health initiatives, but the products sought do not correspond to edaravone or norphenazone formulations.
The code shows minimal recent activity. Seminole County's solicitation is the only identified recent opportunity, posted on June 30, 2026, with an IFB response deadline of July 26, 2023 (note: the due date predates the posting date in the source, indicating a data inconsistency). The county seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Sanford, Florida location. Bidders must submit costs electronically through the county's e-Procurement Portal, provide drug-free workplace certification, comply with E-Verify requirements, and maintain specified insurance coverage. The contract term is two years with a one-year renewal option, and FEMA funding is noted as a potential source, introducing federal compliance requirements. The narrow activity under this code and the category mismatch suggest that vendors should verify code applicability before pursuing opportunities tagged to 51384610, as recent solicitations do not reflect the code's pharmaceutical compound definition.
Quick answers
What is UNSPSC 51384610?
UNSPSC 51384610 is Edaravone or norphenazone, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51384610?
UNSPSC 51384610 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51384610
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code